Dapagliflozin Lowers HbA1c, Systolic Blood Pressure and Serum Uric Acid in Patients With Type 2 Diabetes and Hypertension, Regardless of Class of Concomitant Antihypertensive Therapy

被引：0
|
作者：
Weber, Michael A.
Mansfield, Traci A.
Iqbal, Nayyar
Parikh, Shamik J.
Ptaszynska, Agata
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Diabetes (Type II); Antihypertensive agents; Blood pressure; Hypertension; Glucose;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13640
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Reductions in HbA1c and Systolic Blood Pressure in Patients with Type 2 Diabetes Treated with Dapagliflozin
    Moran, Jason
    Katz, Arie
    Yeh, Helen
    DIABETES, 2015, 64 : A309 - A309
  • [2] Combined HbA1c and Systolic Blood Pressure Reduction With Dapagliflozin in Patients With Both Inadequately Controlled Type 2 Diabetes Mellitus and Hypertension
    Weber, Michael A.
    List, James
    Mansfield, Traci A.
    Parikh, Shamik J.
    Ptaszynska, Agata
    CIRCULATION, 2014, 130
  • [3] Dapagliflozin Reduces HbA1c and Systolic Blood Pressure in Patients with Type 2 Diabetes: Subgroup Analysis Based on Patient Characteristics
    Weber, Michael A.
    Mansfield, Traci A.
    List, James F.
    Ptaszynska, Agata
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [4] Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study
    Scheerer, Markus F.
    Rist, Roland
    Proske, Orm
    Meng, Annika
    Kostev, Karel
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2016, 9 : 337 - 345
  • [5] Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a German primary care database study
    Scheerer, M. F.
    Rist, R.
    Proske, O.
    Meng, A.
    Kostev, K.
    DIABETOLOGIA, 2016, 59 : S337 - S338
  • [6] Association of HbA1c, serum uric acid and non HDL cholesterol in type 2 diabetes patients
    Baral, S.
    CLINICA CHIMICA ACTA, 2019, 493 : S277 - S277
  • [7] Dapagliflozin Lowers Blood Pressure in Patients with Type 2 Diabetes
    Sjostrom, David
    Ptaszynska, Agata
    List, James F.
    Johnsson, Eva
    DIABETES, 2014, 63 : A613 - A613
  • [8] Association of HbA1c, Serum Uric Acid and Non-HDL Cholesterol in Type 2 Diabetes Patients
    Baral, Sushil
    Kshetri, Rupesh
    Mandel, Laxman
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104
  • [9] Achievement of individualized blood pressure and HbA1c targets in patients with hypertension and type-2 diabetes
    Schmieder, R. E.
    Tschoepe, D.
    Koch, C.
    Bramlage, P.
    Ouarrak, T.
    Gitt, A. K.
    EUROPEAN HEART JOURNAL, 2015, 36 : 539 - 539
  • [10] Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes
    Ceriello, Antonio
    De Cosmo, Salvatore
    Rossi, Maria Chiara
    Lucisano, Giuseppe
    Genovese, Stefano
    Pontremoli, Roberto
    Fioretto, Paola
    Giorda, Carlo
    Pacilli, Antonio
    Viazzi, Francesca
    Russo, Giuseppina
    Nicolucci, Antonio
    DIABETES OBESITY & METABOLISM, 2017, 19 (11): : 1570 - 1578
12345